FDA Updates 2026 Human Foods Program Guidance Agenda

FDA Releases Updated 2026 Human Foods Program Guidance Agenda

The U.S. Food and Drug Administration has released an updated version of its 2026 Human Foods Program (HFP) Guidance Agenda, adding three new guidance topics for industry consideration.

The Human Foods Program Guidance Agenda provides insight into guidance documents FDA is actively developing or planning to develop. While inclusion on the agenda does not guarantee publication, the document offers a valuable look at FDA’s current regulatory priorities.

New Topics Added to the 2026 Agenda

FDA added the following guidance topics to the updated agenda:

Labeling Caffeine Content in Foods and Beverages; Draft Guidance for Industry

This draft guidance is expected to address FDA’s current thinking regarding disclosure and labeling of caffeine content in foods and beverages.

Questions and Answers Regarding Use of the “Healthy” Claim

The guidance is expected to provide additional clarification regarding FDA’s updated definition and use of the “healthy” nutrient content claim on food labeling.

Necessity of the Use of Food Product Categories in Food Facility Registrations and Updates to Food Product Categories: Guidance for Industry

This guidance is expected to address food facility registration requirements and FDA’s use of food product categories within registration systems.

Why the Guidance Agenda Matters

FDA typically publishes an initial guidance agenda at the beginning of each calendar year and updates the list as priorities evolve.

For food manufacturers, importers, and regulatory professionals, the agenda can provide early visibility into topics that may affect:

• Product labeling and claims
• Facility registration requirements
• Regulatory compliance programs
• Food safety and reporting obligations
• Future policy and enforcement priorities

While guidance documents do not establish legally enforceable requirements, they often clarify FDA’s current thinking and expectations regarding compliance.

Human Foods Program Focus Areas

The addition of these topics reflects FDA’s continued focus on:

• Food labeling transparency
• Consumer-facing claims
• Food facility registration and reporting systems
• Modernization of regulatory programs

Companies may wish to monitor the development of these guidance documents and evaluate whether future recommendations could affect existing products, labeling, or compliance procedures.

EAS Perspective

FDA’s guidance agendas provide valuable insight into areas where the agency may be developing new interpretations, recommendations, or compliance expectations. Monitoring these agendas can help companies anticipate regulatory developments and prepare for future changes before guidance documents are formally released.